Overexpression of the HER-2/ neu Oncogene in Pancreatic Adenocarcinoma

Article Properties
  • Language
    English
  • DOI (url)
    10.1097/00000421-200110000-00016
  • Publication Date
    2001/10/01
  • Journal
    American Journal of Clinical Oncology
  • Indian UGC (journal)
  • Refrences
    25
  • Citations
    110
  • Howard Safran
  • Margaret Steinhoff
  • Shamlal Mangray
  • Ritesh Rathore
  • Thomas Charles King
  • Li Chai
  • Katya Berzein
  • Todd Moore
  • David Iannitti
  • Philip Reiss
  • Terese Pasquariello
  • Paul Akerman
  • Daniel Quirk
  • Robert Mass
  • Lisa Goldstein
  • Umadevi Tantravahi
Cite
Safran, Howard, et al. “Overexpression of the HER-2 Neu Oncogene in Pancreatic Adenocarcinoma”. American Journal of Clinical Oncology, vol. 24, no. 5, 2001, pp. 496-9, https://doi.org/10.1097/00000421-200110000-00016.
Safran, H., Steinhoff, M., Mangray, S., Rathore, R., King, T. C., Chai, L., Berzein, K., Moore, T., Iannitti, D., Reiss, P., Pasquariello, T., Akerman, P., Quirk, D., Mass, R., Goldstein, L., & Tantravahi, U. (2001). Overexpression of the HER-2/ neu Oncogene in Pancreatic Adenocarcinoma. American Journal of Clinical Oncology, 24(5), 496-499. https://doi.org/10.1097/00000421-200110000-00016
Safran H, Steinhoff M, Mangray S, Rathore R, King TC, Chai L, et al. Overexpression of the HER-2/ neu Oncogene in Pancreatic Adenocarcinoma. American Journal of Clinical Oncology. 2001;24(5):496-9.
Journal Categories
Medicine
Internal medicine
Neoplasms
Tumors
Oncology
Including cancer and carcinogens
Medicine
Medicine (General)
You May Also Like
Refrences
Title Journal Journal Categories Citations Publication Date
Cancer Statistics, 2001 CA: A Cancer Journal for Clinicians
  • Medicine: Medicine (General)
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
 2,388 2001
10.1309/VACP-VLQA-G9DX-VUDF American Journal of Clinical Pathology
  • Medicine: Medicine (General): Medical technology
  • Medicine: Pathology
  • Medicine: Medicine (General)
  • Medicine: Medicine (General)
 2000
Strong Correlation between Results of Fluorescent In Situ Hybridization and Immunohistochemistry for the Assessment of the ERBB2 (HER-2/neu) Gene Status in Breast Carcinoma Modern Pathology
  • Medicine: Medicine (General): Medical technology
  • Medicine: Pathology
  • Medicine: Medicine (General)
  • Medicine: Medicine (General)
 81 2000
HER-2/neu Testing in Breast Carcinoma: A Combined Immunohistochemical and Fluorescence In Situ Hybridization Approach Modern Pathology
  • Medicine: Medicine (General): Medical technology
  • Medicine: Pathology
  • Medicine: Medicine (General)
  • Medicine: Medicine (General)
 128 2000
Determination of Her-2/Neu Status in Breast Carcinoma: Comparative Analysis of Immunohistochemistry and Fluorescent In Situ Hybridization Modern Pathology
  • Medicine: Medicine (General): Medical technology
  • Medicine: Pathology
  • Medicine: Medicine (General)
  • Medicine: Medicine (General)
 149 2000
Refrences Analysis
Category Category Repetition
Medicine: Medicine (General)17
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens6
Medicine: Medicine (General): Medical technology5
Medicine: Pathology4
Medicine: Internal medicine1
Science: Biology (General): Genetics1
The category Medicine: Medicine (General) 17 is the most frequently represented among the references in this article. It primarily includes studies from Human Pathology The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
Title Journal Journal Categories Citations Publication Date
Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer

 BMC Cancer
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Medicine (General)
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
 1 2023
Primary sclerosing cholangitis and pancreatic cancer: A retrospective cohort study of United States veterans

 Frontiers in Gastroenterology
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology
 2023
A Comprehensive Review on the Role of Human Epidermal Growth Factor Receptor 2 (HER2) as a Biomarker in Extra-Mammary and Extra-Gastric Cancers

 Onco
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
 1 2023
Evaluation of HER2Neu Status in Periampullary Cancers in Tertiary Care Centre in Northern India: A Three-Year Retrospective Study Cureus 2023
AlGaN/GaN HEMT Based Biosensor for Detection of the HER2 Antigen Spiked in Human Serum IEEE Transactions on Electron Devices
  • Technology: Electrical engineering. Electronics. Nuclear engineering: Electric apparatus and materials. Electric circuits. Electric networks
  • Science: Physics
  • Technology: Electrical engineering. Electronics. Nuclear engineering: Electronics
  • Technology: Electrical engineering. Electronics. Nuclear engineering: Electronics
 2022
Citations Analysis
Category Category Repetition
Medicine: Medicine (General)77
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens54
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology17
Medicine: Therapeutics. Pharmacology13
Medicine: Public aspects of medicine: Toxicology. Poisons12
Medicine: Pathology9
Medicine: Surgery9
Medicine8
Medicine: Medicine (General): Medical technology8
Science: Biology (General)7
Science: Biology (General): Cytology5
Science: Chemistry: Organic chemistry: Biochemistry5
Science: Biology (General): Genetics5
Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy3
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs3
Technology: Chemical technology: Biotechnology2
Science: Chemistry: General. Including alchemy2
Science: Chemistry2
Medicine: Internal medicine1
Science1
Science: Science (General)1
Science: Chemistry: Analytical chemistry1
Technology: Electrical engineering. Electronics. Nuclear engineering: Electric apparatus and materials. Electric circuits. Electric networks1
Science: Physics1
Technology: Electrical engineering. Electronics. Nuclear engineering: Electronics1
Technology: Chemical technology: Polymers and polymer manufacture1
Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine1
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system1
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system1
Science: Human anatomy1
Science: Physiology1
The category Medicine: Medicine (General) 77 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Advanced Pancreatic Cancer and was published in 2002. The most recent citation comes from a 2023 study titled Evaluation of HER2Neu Status in Periampullary Cancers in Tertiary Care Centre in Northern India: A Three-Year Retrospective Study. This article reached its peak citation in 2012, with 9 citations. It has been cited in 80 different journals, 15% of which are open access. Among related journals, the World Journal of Gastroenterology cited this research the most, with 4 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year